Amneal Pharmaceuticals, Inc. (AMRX) stock analysis

In our weekly check, Amneal Pharmaceuticals, Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 13 pass, warnings: 5, red flags: 5.

About Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in the United States, listed on NYSE as AMRX.

What our checks show for AMRX

Red flags

Warning signs

Strengths

Similar companies

ALKS · LNTH · ELAN · BHC · HCM · VTRS

Questions

What grade does Amneal Pharmaceuticals, Inc. (AMRX) have?

In our weekly check, Amneal Pharmaceuticals, Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 13 pass, warnings: 5, red flags: 5. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of AMRX stock?

This week's biggest flags for Amneal Pharmaceuticals, Inc.: High debt, Thin margins, Deep past fall. In total 10 of 23 checks show a warning or a red flag.

What does Amneal Pharmaceuticals, Inc. do?

Amneal Pharmaceuticals, Inc. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in the United States, listed on NYSE as AMRX.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis